Publicerad: 2025-07-01
Signal Management Specialist
Would you like to contribute to the safer use of medicines and vaccines for everyone everywhere? We are looking for a physician or pharmacist to join our Signal Management section.
Since 1978, Uppsala Monitoring Centre (UMC) has been dedicated to developing, supporting, and expanding the field of pharmacovigilance science and practice.
As a World Health Organization (WHO) Collaborating Centre, UMC operates the WHO Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance of medicines and vaccines, and maintains VigiBase, the WHO global database of adverse event reports.
We are a diverse, international group of pharmacists, physicians, data scientists, system developers, communicators, and many other professionals motivated by a deep belief that the work we do matters.
About the role
The WHO Liaison department has over 20 staff members with diverse skill sets and backgrounds, divided into three sections: Signal Management, Education & Training, and Surveillance Implementation & Strengthening.
You will join the Signal Management section, which consists of eight specialists with educational backgrounds in medicine or pharmacy.
What you will do
With support from UMC’s Research department, the Signal Management section regularly screens VigiBase to detect safety signals. A signal can be defined as information which suggests a new potentially causal association or a new aspect of a known association between a medicine or vaccine and an adverse event. UMC’s signals are primarily intended to alert and inform the national pharmacovigilance centres and regulatory authorities within the Programme for International Drug Monitoring. These organisations are responsible for evaluating the information received and deciding on further action at a national level.
As Signal Management Specialist, you will:
- Perform the clinical assessment of case series related to signals, including causality assessment and reviewing the scientific literature for additional evidence.
- Critically review the signal assessments performed by your team members.
- Disseminate the findings, including publishing in the WHO Pharmaceuticals Newsletter and peer-reviewed scientific journals as well as presenting at scientific conferences.
- Share your expertise in collaborations with other sections and departments within UMC, such as Education & Training and Research.
- Work closely with WHO’s Pharmacovigilance team and assist them in providing support to the WHO advisory committees on the safety of medicinal products (ACSoMP) and vaccines (GACVS).
This is a full-time position based at UMC’s office in the centre of Uppsala, Sweden. The office is conveniently located three minutes away from the railway and bus stations.
Who you are
You:
- Are a medical doctor (MD, MSc) or pharmacist (PharmD, MSc) with recent experience in healthcare, research or pharmacovigilance.
- Have a strong analytical capability and interest.
- Are proficient in scientific writing, with an eye for detail.
- Are fluent in written and spoken English.
- Are proactive and capable of driving activities to completion.
- Like to collaborate with team members and other stakeholders.
- Enjoy contributing to a positive and nurturing work environment.
We will process applications on an ongoing basis during the recruitment period.
Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978 dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance, and maintains VigiBase, the WHO global database of adverse event reports. In addition, UMC provides international standards and related digital solutions for secure exchange of pharmacovigilance data, including a global medicine and vaccine terminology for identification of medicinal products. With around 200 staff, UMC advances the science of pharmacovigilance and transforms its practice through technological innovation.
UMC’s working language is English. We normally apply a probationary period to new appointments.
If you have any questions regarding this position please contact the responsible manager. You will find the contact details at the end of this page.
UMC follows the collective agreements between the Swedish Agency for Government Employers and Saco-S and ST. Union representatives are Malin Zaar (Saco-S) and Jessica Avasol (ST), +46 (0)18-65 60 60.
Since 1978, Uppsala Monitoring Centre (UMC) has been dedicated to developing, supporting, and expanding the field of pharmacovigilance science and practice.
As a World Health Organization (WHO) Collaborating Centre, UMC operates the WHO Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance of medicines and vaccines, and maintains VigiBase, the WHO global database of adverse event reports.
We are a diverse, international group of pharmacists, physicians, data scientists, system developers, communicators, and many other professionals motivated by a deep belief that the work we do matters.
About the role
The WHO Liaison department has over 20 staff members with diverse skill sets and backgrounds, divided into three sections: Signal Management, Education & Training, and Surveillance Implementation & Strengthening.
You will join the Signal Management section, which consists of eight specialists with educational backgrounds in medicine or pharmacy.
What you will do
With support from UMC’s Research department, the Signal Management section regularly screens VigiBase to detect safety signals. A signal can be defined as information which suggests a new potentially causal association or a new aspect of a known association between a medicine or vaccine and an adverse event. UMC’s signals are primarily intended to alert and inform the national pharmacovigilance centres and regulatory authorities within the Programme for International Drug Monitoring. These organisations are responsible for evaluating the information received and deciding on further action at a national level.
As Signal Management Specialist, you will:
- Perform the clinical assessment of case series related to signals, including causality assessment and reviewing the scientific literature for additional evidence.
- Critically review the signal assessments performed by your team members.
- Disseminate the findings, including publishing in the WHO Pharmaceuticals Newsletter and peer-reviewed scientific journals as well as presenting at scientific conferences.
- Share your expertise in collaborations with other sections and departments within UMC, such as Education & Training and Research.
- Work closely with WHO’s Pharmacovigilance team and assist them in providing support to the WHO advisory committees on the safety of medicinal products (ACSoMP) and vaccines (GACVS).
This is a full-time position based at UMC’s office in the centre of Uppsala, Sweden. The office is conveniently located three minutes away from the railway and bus stations.
Who you are
You:
- Are a medical doctor (MD, MSc) or pharmacist (PharmD, MSc) with recent experience in healthcare, research or pharmacovigilance.
- Have a strong analytical capability and interest.
- Are proficient in scientific writing, with an eye for detail.
- Are fluent in written and spoken English.
- Are proactive and capable of driving activities to completion.
- Like to collaborate with team members and other stakeholders.
- Enjoy contributing to a positive and nurturing work environment.
We will process applications on an ongoing basis during the recruitment period.
Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978 dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance, and maintains VigiBase, the WHO global database of adverse event reports. In addition, UMC provides international standards and related digital solutions for secure exchange of pharmacovigilance data, including a global medicine and vaccine terminology for identification of medicinal products. With around 200 staff, UMC advances the science of pharmacovigilance and transforms its practice through technological innovation.
UMC’s working language is English. We normally apply a probationary period to new appointments.
If you have any questions regarding this position please contact the responsible manager. You will find the contact details at the end of this page.
UMC follows the collective agreements between the Swedish Agency for Government Employers and Saco-S and ST. Union representatives are Malin Zaar (Saco-S) and Jessica Avasol (ST), +46 (0)18-65 60 60.